Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Enanta Pharmaceuticals' Treasury Shares history spans 4 years, with the latest figure at $2000.0 for Q2 2015.

  • For Q2 2015, Treasury Shares changed 0.0% year-over-year to $2000.0; the TTM value through Jun 2015 reached $2000.0, changed 0.0%, while the annual FY2014 figure was $2000.0, 0.0% changed from the prior year.
  • Treasury Shares reached $151000.0 in Q4 2025 per ENTA's latest filing, up from $93000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $436000.0 in Q2 2024 to a low of $81000.0 in Q2 2023.
  • Average Treasury Shares over 5 years is $179200.0, with a median of $121000.0 recorded in 2021.
  • The largest YoY upside for Treasury Shares was 0.0% in 2013 against a maximum downside of 0.0% in 2013.
  • A 4-year view of Treasury Shares shows it stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • Per Business Quant, the three most recent readings for ENTA's Treasury Shares are $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014).